Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
TopWeightLoss.ioTreatments Hub

Medvi vs TrimRx vs SHED: The Support-Tier Showdown

Last updated: Sep 1, 2026

Francheska Capistrano, Medical Content Reviewer

Medical reviewer: Francheska Capistrano, RMT, MPH

Reviews this site’s health content for scientific accuracy · How we review

We may earn a commission from links on this page - it never affects our rankings (how we stay objective).

Here’s the short version

These three sell more than medication - each wraps the same compounded GLP-1s in a different support philosophy, from Medvi's current $99 promo to SHED's $199. Medvi bundles video visits, a dietician and care coaching behind a 14,987-review Trustpilot record. TrimRx sells flexibility: no contract, optional discounts, clinical guidance. SHED sells accountability: formal health coaching plus the market's only lose-5%-in-120-days-or-your-money-back guarantee.

Medvi logo
14,987 reviews onTrustpilot
Licensed US telehealth

Summer Sale! up to $100 off

Visit Medvi
TrimRx logo
5,392 reviews onTrustpilot
Licensed US telehealth

Limited time offer - $140 off all weight loss plans

Visit TrimRx
SHED logo
1,134 reviews onTrustpilot
Licensed US telehealth

Get 30% off your first month

Visit SHED

Medvi vs TrimRx vs SHED: side by side

Real published prices and terms - the differences that actually decide this matchup.

MedviTrimRxSHED
Semaglutide$99/mo promo (reg. $199), all-inclusive$149/mo, same at every dose$199/mo (20% off first month)
Tirzepatide$166/mo promo (reg. $299)$259/mo$299/mo (20% off first month)
Billing & commitmentMonthly, all-inclusive - no surprise charges; HSA/FSA approvedMonthly - no long-term contract; multi-month discountsMonthly; HSA/FSA approved
ShippingFree shippingFree home deliveryFree home delivery
SupportVideo visits + free dietician & care coachingLicensed clinical guidance through dose changesProvider visit + health coaching included
Guarantee / refund--Lose 5% of body weight in 120 days or your money back
Standout4.3 on Trustpilot across 14,987 reviewsFlexibility-first: month-to-month always availableThe market's firmest results guarantee

Our verdict

Match the model to your failure mode. If past attempts failed for lack of guidance, Medvi's high-touch care - with the receipts to prove it works - is the pick. If you want premium care without being locked to anything, TrimRx. If you need stakes and structure to follow through, SHED's guarantee literally pays you back if the program doesn't deliver. On current pricing Medvi's $99 promo is also the cheapest of the three - but the support philosophy, not the price, is the real choice.

Medvi vs TrimRx vs SHED: FAQs

Is Medvi, TrimRx or SHED better for support?

They support differently: Medvi includes video visits with providers plus a free dietician and care coaching (rated 4.3 across 14,987 Trustpilot reviews); SHED includes formal health coaching backed by a money-back guarantee; TrimRx includes clinical guidance through dose changes with a flexibility-first, no-contract model.

Which has a money-back guarantee?

SHED - lose 5% of your body weight in 120 days or your money back, conditioned on following the program (terms on its site). Medvi and TrimRx don't advertise results guarantees.

Are these worth it over cheaper GLP-1 providers?

The active ingredients are the same as the $49-$99 budget tier - the premium buys the support layer. If coaching, accountability or a personal provider relationship is what determines whether you stick with treatment, the tier can pay for itself; if you're self-directed, the budget tier delivers the same medication for less.

Break it down two at a time

The head-to-head comparisons between these providers.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)